share_log

啓明醫療-B:截至二零四年十一月三十日止月份之股份發行人的證券變動月報表

VENUS MEDTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2024

HKEX ·  Dec 4, 2024 16:36

Summary by Moomoo AI

截至2024年11月30日,啓明醫療的法定/註冊股本和已發行股份均無變動。普通股H類別在香港聯交所上市,法定/註冊股本總額為441,011,443人民幣,已發行股份數目為441,010,235股,與上月持平。非上市外資股的法定/註冊股本和已發行股份數目也保持不變,分別為1,208人民幣和1,208股。本月內,啓明醫療未有因股份期權計劃或其他協議而發行新股或轉讓庫存股份。購股權計劃的股份期權數目亦無變動,總數為44,101,023股。公司確認所有證券發行及庫存股份出售或轉讓均已獲董事會授權,並遵循相關法律及監管規定。展望未來,啓明醫療將繼續遵循上市規則及法律要求,確保股本結構的穩定性和透明度。
截至2024年11月30日,啓明醫療的法定/註冊股本和已發行股份均無變動。普通股H類別在香港聯交所上市,法定/註冊股本總額為441,011,443人民幣,已發行股份數目為441,010,235股,與上月持平。非上市外資股的法定/註冊股本和已發行股份數目也保持不變,分別為1,208人民幣和1,208股。本月內,啓明醫療未有因股份期權計劃或其他協議而發行新股或轉讓庫存股份。購股權計劃的股份期權數目亦無變動,總數為44,101,023股。公司確認所有證券發行及庫存股份出售或轉讓均已獲董事會授權,並遵循相關法律及監管規定。展望未來,啓明醫療將繼續遵循上市規則及法律要求,確保股本結構的穩定性和透明度。
As of November 30, 2024, Kai Ming Medical's statutory/registered share capital and issued shares were unchanged. Ordinary Class H shares are listed on the Hong Kong Stock Exchange with a total regulated/registered share capital of RMB441,011,443 and the number of shares issued is 441,010,235 shares, which is consistent with the previous month. The regulated/registered share capital and the number of issued shares of non-listed foreign equity also remained unchanged at RMB 1,208 and 1,208 shares, respectively.During this month, Kai Ming Medical did not issue new shares or transfer of stock shares as a result of the stock option plan or other agreements. The number of share options under the Share Option Scheme remained unchanged, totalling 44,101,023 shares. THE COMPANY CONFIRMS THAT...Show More
As of November 30, 2024, Kai Ming Medical's statutory/registered share capital and issued shares were unchanged. Ordinary Class H shares are listed on the Hong Kong Stock Exchange with a total regulated/registered share capital of RMB441,011,443 and the number of shares issued is 441,010,235 shares, which is consistent with the previous month. The regulated/registered share capital and the number of issued shares of non-listed foreign equity also remained unchanged at RMB 1,208 and 1,208 shares, respectively.During this month, Kai Ming Medical did not issue new shares or transfer of stock shares as a result of the stock option plan or other agreements. The number of share options under the Share Option Scheme remained unchanged, totalling 44,101,023 shares. THE COMPANY CONFIRMS THAT ALL SECURITIES ISSUANCE AND SALE OR TRANSFER OF STOCK SHARES HAVE BEEN AUTHORIZED BY THE BOARD OF DIRECTORS AND IN COMPLIANCE WITH RELEVANT LEGAL AND REGULATORY REQUIREMENTS.Looking ahead, Kai Ming Medical will continue to comply with listing rules and legal requirements to ensure the stability and transparency of its share capital structure.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more